Advertisement
U.S. markets close in 4 hours 20 minutes
Advertisement

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
2.6000+0.0600 (+2.36%)
As of 11:40AM EST. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts15121616
Avg. Estimate-0.46-0.47-2.03-1.85
Low Estimate-0.62-0.64-2.31-2.4
High Estimate-0.34-0.33-1.9-1.36
Year Ago EPS-0.66-0.68-2.32-2.03
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts1481515
Avg. Estimate20k10k110k60k
Low EstimateN/AN/AN/AN/A
High Estimate50k50k200k200k
Year Ago Sales47k52k243k110k
Sales Growth (year/est)-57.40%-80.80%-54.70%-45.50%
Earnings History12/30/20223/30/20236/29/20239/29/2023
EPS Est.-0.7-0.62-0.59-0.52
EPS Actual-0.66-0.68-0.53-0.37
Difference0.04-0.060.060.15
Surprise %5.70%-9.70%10.20%28.80%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-0.46-0.47-2.03-1.85
7 Days Ago-0.46-0.47-2.03-1.85
30 Days Ago-0.51-0.53-2.23-2.21
60 Days Ago-0.51-0.52-2.24-2.19
90 Days Ago-0.51-0.52-2.24-2.2
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1081414
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALLOIndustrySector(s)S&P 500
Current Qtr.30.30%N/AN/AN/A
Next Qtr.30.90%N/AN/AN/A
Current Year12.50%N/AN/AN/A
Next Year8.90%N/AN/AN/A
Next 5 Years (per annum)1.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A